HealthcareServices

Anosmia Market Outlook: Growth and Forecast Highlights 2030

February 19, 2026February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the anosmia market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Anosmia Market expected to grow between 2026 and 2030?

The anosmia market size has experienced strong growth in recent years. It is forecast to increase from $3.86 billion in 2025 to $4.23 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.4%. This historical growth can be attributed to several factors including a rise in the incidence of viral-induced anosmia, heightened awareness regarding olfactory disorders, broader availability of diagnostic tools, an expansion of ENT specialty care, and increased reporting of sensory loss.

The anosmia market size is projected to experience robust expansion over the coming years, with expectations to reach $6.07 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.5%. This growth within the forecast period is attributable to several factors, including increasing research into olfactory nerve regeneration, the growing adoption of novel therapies, the expansion of post-infectious care programs, a rising demand for treatments that enhance quality of life, and heightened clinical trial activity. Prominent trends anticipated during this period include a heightened focus on regenerative therapies, a rise in the use of smell training programs, the increasing adoption of targeted pharmacological treatments, an expansion of diagnostic imaging and testing capabilities, and an enhanced emphasis on post-viral recovery management.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18224&type=smp

Which Drivers Are Influencing Market Acceleration In The Anosmia Market?

The increasing occurrence of neurological conditions is anticipated to boost the anosmia market’s expansion in the future. These disorders cover a wide spectrum of ailments impacting the nervous system, such as the brain, spinal cord, and nerves across the body. The growing number of neurological cases stems from an aging demographic and a higher frequency of long-term illnesses like diabetes and high blood pressure. Such disorders can lead to anosmia by harming the smell-related pathways or areas within the brain that process odors, resulting in an impaired capacity to sense or recognize smells. As an illustration, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported in March 2023 that 6.7 million Americans aged 65 and older are currently experiencing Alzheimer’s dementia, a figure projected to increase to 13.8 million by 2060. Consequently, the increased prevalence of neurological disorders is fueling the expansion of the anosmia market.

What Segments Are Identified Within The Structure Of The Anosmia Market?

The anosmia market covered in this report is segmented –

1) By Type: Idiopathic Anosmia, Congenital Anosmia

2) By Treatment: Therapies, Medications

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Idiopathic Anosmia: Partial Idiopathic Anosmia, Complete Idiopathic Anosmia

2) By Congenital Anosmia: Isolated Congenital Anosmia, Syndromic Congenital Anosmia (Associated With Other Conditions Or Syndromes)

Which Innovation Trends Are Advancing Developments Within The Anosmia Market?

Leading companies in the anosmia market are prioritizing the development of sophisticated delivery methods, notably soft-mist nasal sprays, to boost effectiveness, improve drug uptake, and more accurately reach the olfactory area. This technology employs regulated droplet sizes and reduced spray velocity, ensuring optimal delivery to the olfactory region and thus amplifying the therapeutic impact. An illustration of this is seen in April 2025, when Cyrano Therapeutics, a U.S.-based clinical-stage regenerative medicine firm, concluded enrollment for the Phase 2 FLAVOR trial of CYR-064, its soft-mist nasal spray candidate designed to address post-viral smell loss. This product incorporates a patent-protected intranasal formulation of a broad-spectrum phosphodiesterase (PDE) inhibitor, intended to heighten olfactory neuron excitability. Its precise and targeted deposition into the olfactory region is facilitated by the integration of the Ursatec 3K pump system with Resyca’s soft-mist spray technology.

Which Major Industry Participants Are Leading The Anosmia Market Growth?

Major companies operating in the anosmia market are Cyrano Therapeutics, Regeneron Pharmaceuticals, Novartis AG, GlaxoSmithKline PLC, Otsuka Pharmaceutical Co Ltd, Bayer AG, AstraZeneca PLC, Eli Lilly and Company, Pfizer Inc, Sanofi SA, NeuroNascent Inc, Immunome Therapeutics, Olfactory Therapeutics Ltd, ENT Therapeutics Inc, NeuroSense Therapeutics LLC, SmellSense Bio, Olfactricity Therapeutics, Sensory Neurogenics Inc, Olfaxion Biotech, SmellGen Therapeutics, Post-Viral Sensory Recovery Inc, Hyposmia Therapeutics LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anosmia-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Anosmia Market?

North America was the largest region in the anosmia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the anosmia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anosmia Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18224&type=smp

Browse Through More Reports Similar to the Global Anosmia Market 2026, By The Business Research Company

Anoscope Market Report 2026

https://www.thebusinessresearchcompany.com/report/anoscope-global-market-report

Aplastic Anemia Market Report 2026

https://www.thebusinessresearchcompany.com/report/aplastic-anemia-global-market-report

Hyperlipidemia Market Report 2026

https://www.thebusinessresearchcompany.com/report/hyperlipidemia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795